CVS HEALTH P Market Value
| 126650CU2 | 94.00 3.06 3.15% |
| Symbol | 126650CU2 |
126650CU2 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to 126650CU2's bond what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of 126650CU2.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in 126650CU2 on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding CVS HEALTH P or generate 0.0% return on investment in 126650CU2 over 30 days. 126650CU2 is related to or competes with Flexible Solutions, Spyre Therapeutics, GMS, Genfit, Griffon, Centessa Pharmaceuticals, and Regeneron Pharmaceuticals. More
126650CU2 Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure 126650CU2's bond current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess CVS HEALTH P upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 6.48 | |||
| Value At Risk | (1.16) | |||
| Potential Upside | 1.16 |
126650CU2 Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for 126650CU2's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as 126650CU2's standard deviation. In reality, there are many statistical measures that can use 126650CU2 historical prices to predict the future 126650CU2's volatility.| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.07) | |||
| Total Risk Alpha | (0.22) | |||
| Treynor Ratio | (0.44) |
CVS HEALTH P Backtested Returns
CVS HEALTH P secures Sharpe Ratio (or Efficiency) of -0.11, which signifies that the bond had a -0.11% return per unit of risk over the last 3 months. CVS HEALTH P exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm 126650CU2's Standard Deviation of 1.02, mean deviation of 0.44, and Risk Adjusted Performance of (0.03) to double-check the risk estimate we provide. The bond shows a Beta (market volatility) of 0.13, which signifies not very significant fluctuations relative to the market. As returns on the market increase, 126650CU2's returns are expected to increase less than the market. However, during the bear market, the loss of holding 126650CU2 is expected to be smaller as well.
Auto-correlation | -0.13 |
Insignificant reverse predictability
CVS HEALTH P has insignificant reverse predictability. Overlapping area represents the amount of predictability between 126650CU2 time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of CVS HEALTH P price movement. The serial correlation of -0.13 indicates that less than 13.0% of current 126650CU2 price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.13 | |
| Spearman Rank Test | 0.67 | |
| Residual Average | 0.0 | |
| Price Variance | 0.03 |
CVS HEALTH P lagged returns against current returns
Autocorrelation, which is 126650CU2 bond's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting 126650CU2's bond expected returns. We can calculate the autocorrelation of 126650CU2 returns to help us make a trade decision. For example, suppose you find that 126650CU2 has exhibited high autocorrelation historically, and you observe that the bond is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
126650CU2 regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If 126650CU2 bond is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if 126650CU2 bond is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in 126650CU2 bond over time.
Current vs Lagged Prices |
| Timeline |
126650CU2 Lagged Returns
When evaluating 126650CU2's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of 126650CU2 bond have on its future price. 126650CU2 autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, 126650CU2 autocorrelation shows the relationship between 126650CU2 bond current value and its past values and can show if there is a momentum factor associated with investing in CVS HEALTH P.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in 126650CU2 Bond
126650CU2 financial ratios help investors to determine whether 126650CU2 Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in 126650CU2 with respect to the benefits of owning 126650CU2 security.